Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Overview of multiple myeloma (2013) the hematopoietic tumor treatment guideline [Internet]. Japanese Society of Hematology. Available from: https://www.jshem.or.jp/gui-hemali/table.html. (Accessed date 10 May 2017)
2. Philip J, Sarkar RS, Pathak A. Adverse events associated with apheresis procedures: incidence and relative frequency. Asian J Transfus Sci. 2013;7(1):37–41.
3. Kumar S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, et al. Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens. Blood. 2009;114(9):1729–35.
4. Sanofi-aventis (2014) Overview of Mozobil [Internet]. Sanofi-aventis. Available from: https://www.mozobil.com/. Accessed 10 May 2017.
5. Shaughnessy P, Islas-Ohlmayer M, Murphy J, Hougham M, MacPherson J, Winkler K, et al. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide. Biol Blood Marrow Transplant. 2011;17(5):729–36.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献